These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
102 related articles for article (PubMed ID: 1614365)
21. [Oral inhibitors of renin and their potential use as therapeutic agents in treating hypertension]. Abassi Z; Armaly Z; Nakhoul F; Hoffman A Harefuah; 2008 Jun; 147(6):536-42, 573. PubMed ID: 18693632 [TBL] [Abstract][Full Text] [Related]
22. Under pressure: future prospects in hypertension management. Interview by Laura Dormer. Brunner HR Expert Rev Cardiovasc Ther; 2008 Aug; 6(7):921-3. PubMed ID: 18666842 [TBL] [Abstract][Full Text] [Related]
23. Aliskiren (Tekturna) for hypertension. Med Lett Drugs Ther; 2007 Apr; 49(1258):29-31. PubMed ID: 17415282 [No Abstract] [Full Text] [Related]
24. Aliskiren: a novel renin inhibitor for hypertension. Parmar DM; Jadav SP Indian J Physiol Pharmacol; 2007; 51(1):99-101. PubMed ID: 17877301 [No Abstract] [Full Text] [Related]
25. [Lowering blood pressure in obese hypertensive patients. Which antihypertensive drugs are suitable]. Pischon T; Sharma AM MMW Fortschr Med; 2001 Nov; 143(48):34-8. PubMed ID: 11770373 [TBL] [Abstract][Full Text] [Related]
26. Renin inhibition with aliskiren provides additive antihypertensive efficacy when used in combination with hydrochlorothiazide. Villamil A; Chrysant SG; Calhoun D; Schober B; Hsu H; Matrisciano-Dimichino L; Zhang J J Hypertens; 2007 Jan; 25(1):217-26. PubMed ID: 17143194 [TBL] [Abstract][Full Text] [Related]
27. 3,4-Diarylpiperidines as potent renin inhibitors. Lacombe P; Arbour M; Aspiotis R; Cauchon E; Chen A; Dubé D; Falgueyret JP; Fournier PA; Gallant M; Grimm E; Han Y; Juteau H; Liu S; Mellon C; Ramtohul Y; Simard D; St-Jacques R; Tsui GC Bioorg Med Chem Lett; 2012 Mar; 22(5):1953-7. PubMed ID: 22325946 [TBL] [Abstract][Full Text] [Related]
33. Devising new drugs for the treatment of hypertension--"novel drugs targeting hypertension: renin inhibitors and beyond". Booz GW J Cardiovasc Pharmacol; 2007 Jul; 50(1):1-2. PubMed ID: 17666908 [No Abstract] [Full Text] [Related]
34. Inhibition of renin: an updated review of the development of renin inhibitors. Li YC Curr Opin Investig Drugs; 2007 Sep; 8(9):750-7. PubMed ID: 17729187 [TBL] [Abstract][Full Text] [Related]
35. Aliskiren for renin inhibition: a new class of antihypertensives. Van Tassell BW; Munger MA Ann Pharmacother; 2007 Mar; 41(3):456-64. PubMed ID: 17341529 [TBL] [Abstract][Full Text] [Related]
36. Direct renin inhibition with aliskiren in hypertension and target organ damage. Müller DN; Luft FC Clin J Am Soc Nephrol; 2006 Mar; 1(2):221-8. PubMed ID: 17699210 [TBL] [Abstract][Full Text] [Related]
37. [SP 54 therapy in hypertension. The effect of SP 54 on blood pressure, renin and aldosterone as well as electrolyte balance in patients with hypertension]. Werning C; Stiel D; Hammann K; Schweikert HU; Fischer N; Siegenthaler W Fortschr Med; 1972 Jul; 90(20):785-7. PubMed ID: 5074231 [No Abstract] [Full Text] [Related]
38. Aliskiren for hypertension: just another option or something truly unique? Lee S S D Med; 2007 Oct; 60(10):405-6. PubMed ID: 18019776 [No Abstract] [Full Text] [Related]
40. A comparison of the tolerability of the direct renin inhibitor aliskiren and lisinopril in patients with severe hypertension. Strasser RH; Puig JG; Farsang C; Croket M; Li J; van Ingen H J Hum Hypertens; 2007 Oct; 21(10):780-7. PubMed ID: 17541390 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]